O. James Sterling - Jul 1, 2024 Form 4 Insider Report for bluebird bio, Inc. (BLUE)

Role
Chief Financial Officer
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol
BLUE
Transactions as of
Jul 1, 2024
Transactions value $
$0
Form type
4
Date filed
7/3/2024, 04:05 PM
Previous filing
Jun 13, 2024
Next filing
Oct 2, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLUE Stock Options (Right to buy) Award $0 +300K $0.00 300K Jul 1, 2024 Common Stock 300K $0.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests over a four-year period at the rate of 25% on July 1, 2025, and then in equal monthly installments for the remaining 36 months.